“…In addition, following neural damage, NSC-derived progeny are re-directed to areas of degeneration, where they are involved in wound healing and cell replacement and can serve as a target for therapeutic manipulations (Benner et al, 2013;de Chevigny et al, 2008;Erlandsson et al, 2011;Kolb et al, 2007). NSC activity decreases naturally during aging and is dysregulated in models of neurodegenerative diseases, suggesting an involvement in aging-and disease-associated cognitive deficits (Bouab et al, 2011;Demars et al, 2010;Hamilton et al, 2010;Hamilton et al, 2013;Lazarov and Marr, 2010;. Consistent with this, disturbances in neurogenesis have been reported in Alzheimer's disease (AD) patients (Crews et al, 2010;Perry et al, 2012;Ziabreva et al, 2006) and a range of AD transgenic mouse models (Chuang, 2010;Hamilton et al, 2010).…”